CRH (CRH) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
7 Jan, 2026Executive summary
Delivered 11th consecutive year of margin improvement in 2024, with industry-leading, double-digit profit growth and outperformance versus US and global peers.
Maintained market leadership in North America and Europe, leveraging unmatched scale, a customer-connected solution strategy, and disciplined capital allocation.
Strategic focus on higher growth markets, particularly in the U.S. and Europe, with a uniquely connected portfolio.
Strong operational execution, disciplined capital allocation, and ongoing innovation drive consistent outperformance.
Financial highlights
Full year revenues reached $35.6 billion, up 2% year-over-year, with Q4 revenues at $8.9 billion, also up 2%.
Adjusted EBITDA rose 12% to $6.9 billion, with 180 basis points of margin expansion to 19.5%.
Earnings per share increased 18% year-over-year to $5.48 (pre-impairment).
Return on invested capital improved to 15.5%, up 20 basis points.
Organic growth was driven by positive pricing, operational efficiency, and cost control.
Outlook and guidance
2025 guidance: Adjusted EBITDA of $7.3–$7.7 billion, net income of $3.7–$4.1 billion, diluted EPS of $5.34–$5.80, and capex of $2.8–$3.0 billion.
Positive market backdrop expected in both Americas and international markets, with infrastructure and non-residential segments leading growth.
Residential new-build activity to remain subdued in the U.S., but repair/remodel resilient; international residential stabilizing, with early signs of improvement in Central & Eastern Europe.
Expecting continued margin expansion and growth, supported by robust backlogs and funding tailwinds.
Latest events from CRH
- Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026 - Record 2025 financials, double-digit EBITDA growth, and strong 2026 outlook on infrastructure demand.CRH
Q4 202519 Feb 2026 - Q2 net income up 8%, EBITDA up 12%, margins expanded, and FY24 guidance raised.CRH
H1 20242 Feb 2026 - Q3 saw strong sales, margin gains, and M&A, with a positive outlook reaffirmed.CRH
Q3 2024 TU16 Jan 2026 - Record Q3, raised FY25 EBITDA guidance, and strong outlook driven by demand and acquisitions.CRH
Q3 2025 TU21 Dec 2025 - Record financials, new equity plan, governance updates, and strong ESG progress headline the proxy.CRH
Proxy Filing2 Dec 2025 - Record results, NYSE transition, new CEO, and 12 key AGM proposals mark a transformative year.CRH
Proxy Filing2 Dec 2025 - Definitive additional proxy materials filed for upcoming shareholder meeting.CRH
Proxy Filing2 Dec 2025